These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 8944676)
1. The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt-induced cardiac fibrosis. Young MJ; Funder JW Am J Physiol; 1996 Nov; 271(5 Pt 1):E883-8. PubMed ID: 8944676 [No Abstract] [Full Text] [Related]
2. Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism. Kobori H; Ichihara A; Suzuki H; Takenaka T; Miyashita Y; Hayashi M; Saruta T Am J Physiol; 1997 Aug; 273(2 Pt 2):H593-9. PubMed ID: 9277473 [TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin system and minoxidil-induced cardiac hypertrophy in rats. Ruzicka M; Leenen FH Am J Physiol; 1993 Nov; 265(5 Pt 2):H1551-6. PubMed ID: 8238566 [TBL] [Abstract][Full Text] [Related]
4. Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy. Takeda Y; Yoneda T; Demura M; Usukura M; Mabuchi H Circulation; 2002 Feb; 105(6):677-9. PubMed ID: 11839620 [TBL] [Abstract][Full Text] [Related]
5. Effect of losartan on short-term variability of blood pressure of renovascular hypertensive rats: a spectral study. Ponchon P; Grichois ML; Elghozi JL J Hypertens Suppl; 1993 Dec; 11(5):S244-5. PubMed ID: 8158366 [No Abstract] [Full Text] [Related]
6. Effect of sympathetic and angiotensin-aldosterone systems on renal salt conservation in the rat. Honrath U; Veress AT; Chong CK; Sonnenberg H Am J Physiol; 1997 Apr; 272(4 Pt 2):F538-44. PubMed ID: 9140056 [TBL] [Abstract][Full Text] [Related]
7. Effects of enalapril versus losartan on regression of volume overload-induced cardiac hypertrophy in rats. Ruzicka M; Yuan B; Leenen FH Circulation; 1994 Jul; 90(1):484-91. PubMed ID: 8026035 [TBL] [Abstract][Full Text] [Related]
8. Effect of acute and chronic losartan treatment on glucose tolerance and insulin sensitivity in fructose-fed rats. Iyer SN; Katovich MJ Am J Hypertens; 1996 Jul; 9(7):662-8. PubMed ID: 8806978 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II? O'Sullivan JB; Black MJ; Bertram JF; Bobik A J Hypertens; 1994 Oct; 12(10):1163-70. PubMed ID: 7836732 [TBL] [Abstract][Full Text] [Related]
10. Additive effects of combined valsartan and spironolactone on cardiac aldosterone escape in spontaneously hypertensive rats. Liang YH; Wang JM; Zhou Y; Jiang XJ; Jiang H; Huang CX Life Sci; 2004 Aug; 75(15):1871-8. PubMed ID: 15302230 [TBL] [Abstract][Full Text] [Related]
11. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats. Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697 [TBL] [Abstract][Full Text] [Related]
12. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review. Dahlöf B J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480 [TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling. Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats. Golomb E; Abassi ZA; Cuda G; Stylianou M; Panchal VR; Trachewsky D; Keiser HR Am J Physiol; 1994 Oct; 267(4 Pt 2):H1496-506. PubMed ID: 7524366 [TBL] [Abstract][Full Text] [Related]
15. Use of losartan to examine the role of the cardiac renin-angiotensin system in myocardial dysfunction during ischemia and reperfusion. Werrmann JG; Cohen SM J Cardiovasc Pharmacol; 1996 Feb; 27(2):177-82. PubMed ID: 8720414 [TBL] [Abstract][Full Text] [Related]
17. Olmesartan combined with renal denervation reduces blood pressure in association with sympatho-inhibitory and aldosterone-reducing effects in hypertensive mice with chronic kidney disease. Nishihara M; Takesue K; Hirooka Y Clin Exp Hypertens; 2019; 41(3):211-219. PubMed ID: 29694249 [TBL] [Abstract][Full Text] [Related]
18. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats. Endemann DH; Touyz RM; Iglarz M; Savoia C; Schiffrin EL Hypertension; 2004 Jun; 43(6):1252-7. PubMed ID: 15117913 [TBL] [Abstract][Full Text] [Related]